Benchmark Holdings PLC

Benchmark Holdings says licensing talks hit by delays

The aquaculture health group said it will accelerate the programme of disposals and structural efficiencies

Benchmark Holdings PLC -
Conditions in the shrimp market have been challenging in 2019

Benchmark Holdings PLC said it does not expect to complete a commercial licensing deal before its September year-end.

As a result, the aquaculture health group is accelerating the programme of disposals and structural efficiencies.

The discussions with third parties about licensing its non-core animal vaccines have been subject to delays, Benchmark said.

Conditions in the shrimp and seabass markets have been challenging in 2019 after a record shrimp harvest last year has forced customers to cut production, which has knocked demand for products such as fish feed, vaccines and water treatments.

The company is in the midst of a five-year strategy to drive growth and profitability.

Quick facts: Benchmark Holdings PLC

Price: £0.48

Market: AIM
Market Cap: £268.03 m


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Benchmark Holdings PLC named herein, including the promotion by the Company of Benchmark Holdings PLC in any Content on the Site, the Company...



Benchmark Holdings well placed to deliver on its five-year strategy

Benchmark Holdings PLC's (LON:BMK) Malcolm Pye and Mark Plampin talk through the firm's results for the six months to 31 March 2019. They say they're on track to meet their strategy goals after navigating what's been a challenging shrimp market to deliver a 25% rise in first-half...

on 27/6/19

2 min read